What I'm comparing, and why
I'm the quality and brand compliance manager at a 340-bed hospital system in the Midwest. Every purchase order that reaches the doctors and clinics we serve crosses my desk first—roughly 215 items a year between orthopedic shipments, dental clinic deliveries, and lab equipment intake.
Last year about 16% of first deliveries came back with a red tag—my initials and a line through the packing slip. Not because the implants or instruments were defective. Because the paperwork, labels, or training inserts didn't match what the contract said they would.
Every one of those rejections traced back to a procurement decision made before the order was placed: single-vendor sourcing through a broad-portfolio supplier like Zimmer Biomet, or category-by-category ordering from specialist vendors. I've red-tagged shipments under both models, so I don't push you toward either one.
Here's the framework I use. Four dimensions, one verdict per dimension. No "it depends" at the end of every paragraph.
Dimension 1: Portfolio coverage
Zimmer Biomet's catalog is deep in two places: orthopedic reconstruction (joints, trauma, spine, the ROSA robotic platform) and dental (implants, abutments, restorative components). For a hospital consolidating orthopedic and dental vendors, that's genuine breadth.
But broad isn't the same as everything. Pull up any consolidated-portfolio pitch and it implies one vendor can handle the whole clinical stack. Walk through an actual order history and the gaps show up fast. Our obstetrics floor runs fetal monitors. Our dental clinics need an actual dental chair—the delivery-system chair, not the implant. Our pathology lab runs a flow cytometer. Zimmer Biomet makes none of those.
That's not a knock on the portfolio. It's a clarification of what "consolidated" actually covers. If your spend is concentrated in orthopedics and dental, a consolidated vendor handles most of it. If you also buy monitoring, seating, and lab analytics, you're already sourcing category-by-category—whether or not you've formalized it internally.
Dimension 2: Dental implant customer service
This is where I expected the consolidated vendor to lose. It didn't.
When we trialed Zimmer Biomet dental implants across three clinics in Q2 2024, I tracked first-response times manually—spreadsheet, timestamps, nothing fancy. Across 47 support tickets filed over 90 days, the median first response was around 6 business hours. Transplant-level questions (prosthetic compatibility, torque specs on abutment screws) went to a named specialist who called back the same day. On paper, the specialists we'd used before should have beaten them on responsiveness—focus, smaller ticket volume. The data said specialists would win. My gut said wait. The gut was right.
The second half of the story is less flattering. Response times held through month three, then drifted. By month five the median had stretched to about 14 hours on the dental side (note to self: this is now a quarterly tracking item, not a one-off). Whether that's staffing growth or queue saturation, I can't tell from outside.
What I can tell you: first-month service is a poor proxy for ongoing service. The first month of any vendor relationship gets concierge-level attention. Month four is where the truth lives.
Dimension 3: Reverse shoulder surgical technique
I had to learn what reverse shoulder mechanics actually are before I could evaluate the documentation. Short version: the geometry is flipped from an anatomic shoulder—the glenoid gets a spherical component, the humerus gets a cup—which changes how the deltoid does its work. Different motion mechanics, different learning curve, different training needs.
The surgical theory isn't my job. The surgeon handles that. My job is whether the Zimmer Biomet reverse shoulder surgical technique guide we ship matches what the OR team was trained on, in the same units, using the same anatomical landmarks, with no ambiguity on reaming depth or baseplate orientation.
I've been burned on this before. In 2022 we brought in a different shoulder platform (not Zimmer Biomet) and the technique guide shipped with measurement units inconsistent between pages—one section in millimeters, another in inches, no conversion note. We caught it in intake, but only because a scrub tech flagged a number that didn't look right. Now every orthopedic contract we sign carries a unit-standard line, separate from the delivery spec.
On the reverse shoulder package, the numbers were consistent. What wasn't consistent was the training delivery—one rep walked the OR team through the full glenoid baseplate reaming sequence, another summarized it in ten minutes. Looking back, I should have put the training-documentation expectation into the contract, not just the delivery spec. At the time, I assumed training was training. It isn't. Training is a deliverable, and deliverables need specs.
Dimension 4: The categories the vendor doesn't make
Back to the fetal monitor, the dental chair, and the flow cytometer.
A fetal monitor is straightforward to source separately—well-established manufacturer base, and the buying criteria (FHR accuracy, dual-channel monitoring, EMR connectivity) are already familiar to anyone running an OB floor.
A dental chair is mostly a logistics purchase. The chair itself isn't the hard part. The utility rough-in, the delivery path, and whether the install takes an operatory out of commission for one day or three—those are the hard parts.
Flow cytometry is the one that trips people up. If you've ever sat through a lab equipment review and had to ask "what is flow cytometry" (I did—2023, mid-meeting, no shame), the working definition is this: a technique that passes cells single-file through a laser and measures how they scatter and fluoresce. That lets the lab sort and count cell populations by surface marker. For a mid-size hospital it means one or two dedicated instruments, a service contract that specifies on-site response time, and a validation protocol you'll re-run after any major service event.
None of these three belong in a consolidated orthopedic-and-dental sourcing plan. Forcing them in creates a coverage that only exists on the vendor slide.
So which model, for which case
My recommendation, by scenario.
If your spend is concentrated in orthopedics and dental—joints, trauma, implants, instruments, robotic-assist platforms—a consolidated vendor like Zimmer Biomet is the reasonable default. Training is coordinated, implant-to-instrument compatibility is guaranteed, and the negotiation is one conversation instead of eight.
If your acquisitions cross into obstetrics, clinic fit-out, or lab analytics, split. The integrated-vendor argument doesn't cover categories the vendor doesn't make, and pretending otherwise just hides a second sourcing project inside the first. There's something satisfying about finally mapping this out on one page—after four years of juggling spreadsheets, the whole matrix fits in a single view. It also stops surprising me every time a new department asks for a device that isn't in the main catalog.
If you're under 100 beds and don't have a dedicated biomedical engineering team—I'd lean consolidated even where coverage is imperfect. Coordination cost of five vendors with a 1.5-person procurement office is higher than the savings. (We're at 340 beds and I'm still not certain we've got the coordination math right. At 100, I wouldn't even try.)
The customer service question is the one I'd flag for anyone in year one of a consolidated relationship. Track your response times on something you can hold the vendor to. "Good service" isn't a spec. "First response within one business day, specialist escalation within two" is a spec. Write it in. Then track the drift at month four—because that's when the real number shows up.
The honest limitation: I wouldn't recommend Zimmer Biomet as your sole vendor unless you've checked what's actually not in the catalog. That's not a weakness of the product line. It's the shape of a portfolio that's deep in two categories and intentionally absent everywhere else.